Ledger.Open graph →
SEC Form D · filed April 23, 2014

Nora Therapeutics, Inc

Offering
$18.0M
Sold
$18.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PALO ALTO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Martin J. Vogelbaum · New York, NYDirectorChen E. Yu · Palo Alto, CADirectorJef J. Boeke · New York, NYDirectorTerry Opdendyk · Palo Alto, CADirectorDavid E. Schnell · Palo Alto, CADirectorChris Agerton · San Francisco, CAExec · DirectorBryant E. Fong · San Francisco, CADirectorByron Deeter · Palo Alto, CADirectorRobert Antoniades · Palo Alto, CAExec · DirectorJim Kelliher · Palo Alto, CADirectorWilliam A. Ferer · Jersey City, NJDirectorRonald J. Sorenson · Jersey City, NJDirectorTimothy O. Porter · Jersey City, NJDirectorMichael Mascis · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗